Print

Canada's EndoCeutics Lowers IPO Price to $7-$9  
5/10/2007 8:56:41 AM

WASHINGTON, May 9 (Reuters) - Canada's EndoCeutics Inc., a pharmaceutical firm, lowered the price of its planned initial public offering to between $7 and $9 per share from between $11-$13 each.

>>> Discuss This Story


//-->